BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12704456)

  • 21. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
    Busam KJ
    Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
    Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
    J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new American Joint Committee on Cancer staging system for cutaneous melanoma.
    Balch CM; Buzaid AC; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Houghton A; Kirkwood JM; Mihm MF; Morton DL; Reintgen D; Ross MI; Sober A; Soong SJ; Thompson JA; Thompson JF; Gershenwald JE; McMasters KM
    Cancer; 2000 Mar; 88(6):1484-91. PubMed ID: 10717634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Histological classification and assessment of malignant melanomas].
    Hornstein OP
    Haematol Blood Transfus; 1978; 21():249-75. PubMed ID: 738637
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular staging of melanoma.
    Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
    Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
    [No Abstract]   [Full Text] [Related]  

  • 27. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
    Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE
    Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
    Duraker N; Caynak ZC
    Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment of a 2-stage prognostic classification of primary malignant melanoma derived from a multidimensional analysis and from an agreement study].
    Chastang C; Césarini JP; Beltzer-Garelli H; Palangié A; Jacquillat C; Puissant A; Banzet P
    Rev Epidemiol Sante Publique; 1984; 32(3-4):243-8. PubMed ID: 6395231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
    Ross MI
    Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
    Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of sentinel node biopsy in patients with cutaneous melanoma.
    Aldredge LM
    Nurs Clin North Am; 2007 Sep; 42(3):379-92, v-vi. PubMed ID: 17825660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of early-stage cutaneous melanoma.
    Aloia TA; Gershenwald JE
    Curr Probl Surg; 2005 Jul; 42(7):460-534. PubMed ID: 16099230
    [No Abstract]   [Full Text] [Related]  

  • 36. How pathologic staging informs the surgical management of primary cutaneous melanoma.
    Tsai S; Balch CM
    G Ital Dermatol Venereol; 2010 Apr; 145(2):187-93. PubMed ID: 20467392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of surgery in the treatment of malignant melanoma].
    Péley G; Farkas E; Mátrai Z; Rényi-Vámos F; Kovács T; Köves I
    Magy Onkol; 2003; 47(1):69-77. PubMed ID: 12704458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, staging (new system), and prognosis of cutaneous melanoma.
    Cho YR; Chiang MP
    Clin Plast Surg; 2010 Jan; 37(1):47-53. PubMed ID: 19914457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in melanoma histopathology and diagnosis.
    Piris A; Mihm MC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.